UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHED...
0001636050false2021FYP3Y0.1250.1250.125505033.3333.3300016360502020-04-012021-03-31iso4217:USD00016360502020...
– Multiple GM1 gangliosidosis program milestones expected in FY2021, including 12-month data updates from the...
NEW YORK and RESEARCH TRIANGLE PARK, N.C, May 19, 2021 (GLOBE NEWSWIRE) -- Sio Gene Therapies Inc. (NASDAQ:...
false000163605000016360502021-05-132021-05-13 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...
- GM1 ganglioside in CSF reduced in 4 out of 5 children treated with the lowest dose at 6 months follow-up...
NEW YORK, and RESEARCH TRIANGLE PARK, N.C., April 28, 2021 (GLOBE NEWSWIRE) -- Sio Gene Therapies Inc...
FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.